Type 2 inflammation influences the severity of post-acute sequelae of SARS-CoV-2, highlighting the need for targeted interventions. Innovative therapies like ALIS, tezepelumab, and dupilumab show ...
ATS Corporation (TSE:ATS) has released an update. ATS Corporation, a leader in automation solutions, will have its CEO and CFO participate in the Baird 2024 Global Industrial Conference in Chicago, ...
CAMBRIDGE, Ontario--(BUSINESS WIRE)--ATS Corporation (TSX: ATS) (NYSE: ATS) (“ATS” or the “Company”) today released its FY2024 Sustainability Report, for the period ending March 31, 2024. This report, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results